Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares fell 6.7% on Wednesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 41,343 shares traded hands during trading, a decline of 96% from the average session volume of 1,048,565 shares. The stock had previously closed at GBX 1.50 ($0.02).
Cizzle Biotechnology Price Performance
The business has a 50 day simple moving average of GBX 1.61 and a 200 day simple moving average of GBX 1.78. The company has a market capitalization of £5.52 million, a price-to-earnings ratio of -1,953.67 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- Industrial Products Stocks Investing
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- How to Evaluate a Stock Before Buying
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- How to Choose Top Rated Stocks
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
